Netherlands sees unexpected surge in Mycoplasma pneumoniae cases, younger population more affected

A study in the Netherlands reports a significant rise in Mycoplasma pneumoniae infections since October 2023, with a notable decrease in the median age of patients compared to the last epidemic.

FDA accepts Alpha Cognition’s NDA for Alzheimer’s treatment

Share this article ALPHA-1062 is intended to treat mild-to-moderate Alzheimer’s disease. Credit: PopTika / Shutterstock.com. The US Food and Drug Administration (FDA) has accepted Alpha

December 8, 2023

U.S. Overdose Deaths Are Down, Giving Experts Hope for an Enduring Decline

The decline in U.S. drug overdose deaths appears to have continued this year, giving experts hope the nation is seeing sustained improvement in the persistent

November 14, 2024

TRANSFORM Trial Unveiled: AI-Powered Approach for Personalized Heart Disease Care

Cleerly, a leading innovator in the field of cardiovascular disease diagnosis, today announced the launch of the TRANSFORM trial at the American Heart Association’s (AHA)

November 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.